Diagnostic value of CT enhancement degree in lymph node metastasis of papillary thyroid cancer: A comparison of enhancement, ratio, and difference

被引:2
作者
Zhu, Jiying [1 ]
Tian, Min [1 ]
Zhang, Tong [1 ]
Zhu, Hanlin [2 ]
Wei, Peiying [1 ]
Han, Zhijiang [1 ]
机构
[1] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Radiol, Sch Med, Hangzhou, Peoples R China
[2] Hangzhou Ninth Peoples Hosp, Dept Radiol, Hangzhou, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词
lymph node metastasis; thyroid nodule; thyroid tumor; tomography; x-ray computer; CARCINOMA; ULTRASONOGRAPHY; ULTRASOUND; ACCURACY;
D O I
10.3389/fendo.2023.1103434
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesTo evaluate the value of computed tomography (CT) enhancement degree in diagnosing lymph node (LN) metastasis in papillary thyroid carcinoma (PTC) by determining the ratio and difference between the Hounsfield units (HU) of CT enhancement and plain scan of the LNs, as well as between the HU of CT-enhanced LNs and the sternocleidomastoid muscle. MethodsThe plain and enhanced CT findings of 114 metastasis-positive LNs in 89 cases and 143 metastasis-negative LNs in 114 cases of PTC were analyzed retrospectively. Plain HU of LNs (PNHU), enhanced HU of LNs (ENHU), and enhanced HU of the sternocleidomastoid muscle (EMHU) were measured. The ENHU, difference between ENHU and PNHU (EN-PNHU), ratio of ENHU to PNHU (EN/PNHU), difference between ENHU and EMHU (EN-EMHU), and ratio of ENHU to EMHU (EN/EMHU) in metastasis-positive and metastasis-negative LN groups were calculated, the corresponding diagnostic efficacy for differentiating metastasis-positive from metastasis-negative LNs in PTC were sought using the receiver-operating curve. The interobserver agreement between readers was assessed using the interobserver correlation coefficient (ICC). ResultsThe ENHU of 114 metastasis-positive LNs and 143 metastasis-negative LNs was 113.39 +/- 24.13 and 77.65 +/- 15.93, EN-PNHU was 65.84 +/- 21.72 HU and 34.07 +/- 13.63 HU, EN/PNHU was 2.36 (1.98, 2.75) and 1.76 (1.54, 2.02), EN-EMHU was 49.42 +/- 24.59 HU and 13.27 +/- 15.41 HU, and EN/EMHU was 1.79 +/- 0.40 and 1.21 +/- 0.24, respectively (all P < 0.001). The area under the curve, cutoff value, sensitivity, specificity, and accuracy of ENHU for identifying metastasis-positive and metastasis-negative LNs were 0.895, 97.3 HU, 0.746, 0.895, and 0.829, EN-PNHU was 0.894, 47.8 HU, 0.807, 0.874, and 0.844, EN/PNHU was 0.831, 1.9, 0.877, 0.650, and 0.751, EN-EMHU was 0.890, 26.4 HU, 0.807, 0.839, and 0.825, and EN/EMHU was 0.888, 1.5, 0.728, 0.902, and 0.825, respectively. The readers had an excellent interobserver agreement on these five parameters (ICC = 0.874-0.994). ConclusionIn the preoperative evaluation of LN metastasis in PTC, ENHU, EN-PNHU, EN-EMHU, and EN/EMHU had similarly high diagnostic efficacy, with ENHU, EN-PNHU, and EN/EMHU having higher specificity and EN-PNHU and EN-EMHU having higher sensitivity.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Impact of Lymph Node Ratio on Survival in Papillary Thyroid Cancer
    Schneider, David F.
    Chen, Herbert
    Sippel, Rebecca S.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (06) : 1906 - 1911
  • [22] Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer
    Li Genpeng
    Lei Jianyong
    You Jiaying
    Jiang Ke
    Li Zhihui
    Gong Rixiang
    Zhang Lihan
    Zhu Jingqiang
    [J]. MEDICINE, 2018, 97 (05)
  • [23] Leptin as a predictive marker for lymph node metastasis in patients with papillary thyroid cancer
    Abdelrahim, Hossam S.
    Mohamed, Mohamed A.
    Elshafei, Mahmoud A.
    Farahat, Mahmoud S.
    Goda, Mohammed H.
    [J]. EGYPTIAN JOURNAL OF SURGERY, 2024, 43 (01) : 42 - 49
  • [24] Prognostic value of lymph node ratio in metastatic papillary thyroid carcinoma
    Mansour, J.
    Sagiv, D.
    Alon, E.
    Talmi, Y.
    [J]. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2018, 132 (01) : 8 - 13
  • [25] Incidence and clinical characteristics of prelaryngeal lymph node metastasis in papillary thyroid cancer
    Lee, Young Chan
    Shin, Seung Youp
    Kwon, Kee Hwan
    Eun, Young Gyu
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2013, 270 (09) : 2547 - 2550
  • [26] Diagnostic value of microRNA-129-5p and TSH combination for papillary thyroid cancer with cervical lymph node metastasis
    Shen, Yi
    Xie, Rongli
    Chen, Yupan
    Han, Xujie
    Li, Xiao-en
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2025, 40 (01) : 46 - 54
  • [27] Lymph node fine-needle aspiration washout thyroglobulin in papillary thyroid cancer: Diagnostic value and the effect of thyroglobulin antibodies
    Degertekin, Ceyla Konca
    Yalcin, Mehmet Muhittin
    Cerit, Turgay
    Ozkan, Cigdem
    Kalan, Isilay
    Iyidir, Ozlem Turhan
    Altinova, Alev Eroglu
    Akturk, Mujde
    Toruner, Fusun
    Akin, Murat
    Cakir, Nuri
    [J]. ENDOCRINE RESEARCH, 2016, 41 (04) : 281 - 289
  • [28] Lymph node metastasis in the suprasternal space from thyroid papillary cancer
    Homma, Akihiro
    Hatakeyama, Hiromitsu
    Mizumachi, Takatsugu
    Furusawa, Jun
    Kano, Satoshi
    Sakashita, Tomohiro
    Fukuda, Satoshi
    [J]. INTERNATIONAL CANCER CONFERENCE JOURNAL, 2015, 4 (01): : 57 - 60
  • [29] Cystic lymph node metastasis of papillary thyroid cancer: clinical facts
    Lindner, Kirsten
    Tharun, Lars
    Bayer, Andreas
    Kussmann, Jochen
    Fendrich, Volker
    [J]. MINERVA SURGERY, 2021, 76 (06): : 598 - 603
  • [30] Diagnostic Value of FDG-PET/CT for Lymph Node Metastasis of Colorectal Cancer
    Kwak, Jae Young
    Kim, Jae Seung
    Kim, Hye Jin
    Ha, Hyun Kwon
    Yu, Chang Sik
    Kim, Jin Cheon
    [J]. WORLD JOURNAL OF SURGERY, 2012, 36 (08) : 1898 - 1905